Even in the earliest stages, generating and securing intellectual property is a critical component of a company’s business plan. Many early-stage companies rely on outside counsel to do the heavy lifting, but what should be done (or not done) internally with respect to IP? What can a company do to help maximize its relationship with outside counsel, while keeping a realistic budget? How can a company best manage its research and develop teams to capture IP? When is it time to start building an internal IP team? What can be done internally to help prepare for a financing? Where can things go wrong? Here’s your chance to learn from the best: Join our August 28 panel with Randy Wu of 10x Genomics, Yina Dong of Veracyte, Rachel Herder of Mammoth Biosciences and Aric Ledford of Freenome, moderated by Ali Alemozafar and Adam Cole of Wilson Sonsini Goodrich & Rosati.
Sonia El-Feki
selfeki@wsgr.comAli counsels clients on patent strategy, prosecution, and diligence for financings, M&A, and IPOs.
Dr. Adam Cole is an associate in the San Francisco office of Wilson Sonsini Goodrich & Rosati.